Routine testing after aneurysm coiling carries low risk
Nov 18, 2008 |
not rated yet |
0
A very low risk of complication is associated with a routine test that determines whether a brain aneurysm treated with endovascular coiling has started to recur, a study led by the University of Cincinnati Neuroscience Institute ...
K-State helps nursing home staff become comfortable with residents' sexual expression
Nov 18, 2008 |
not rated yet |
0
"Do not disturb" signs aren't just for newlyweds anymore. They are also a way to give nursing home residents some privacy for sexual expression, according to Kansas State University aging experts.
Individuals with HIV have higher risk of non-AIDS cancers
Medicine & Health / HIV & AIDS
Nov 18, 2008 |
not rated yet |
0
The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International ...
Alcohol sponsorship linked to hazardous drinking in sportspeople
Nov 18, 2008 |
not rated yet |
0
A new study provides the first evidence of a link between alcohol-industry sponsorship and hazardous drinking among sportspeople.
Poor understanding of medicare leads to worse healthcare access
Nov 18, 2008 |
not rated yet |
0
A study appearing in Journal of the American Geriatrics Society shows that Medicare beneficiaries' understanding of their healthcare benefits may affect their ability to access needed care effectively and could lead them t ...
LLNL, industry leaders to develop advanced technology cluster testbed
Technology / Computer Sciences
Nov 18, 2008 |
not rated yet |
0
The National Nuclear Security Administration's (NNSA) Lawrence Livermore National Laboratory has teamed with 10 computing industry leaders to accelerate the development of powerful next-generation Linux clusters in a project ...
Widely used cancer drug associated with significantly increased risk of blood clots
Medicine & Health / Medications
Nov 18, 2008 |
not rated yet |
0
An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according ...
